Pathlab are pleased to announce the local implementation of an extended respiratory viral panel on the Qiastat-Dx molecular platform based at Pathlab Bay of Plenty. This is a multiplex assay using polymerase chain reaction (PCR) technology.
Validation has now been completed on this assay and it is now available to clinicians at Tauranga, Whakatane, Rotorua and Taupo Hospitals. It has a turnaround time of one working day.
The assay contains the following viral targets:
Test requests for the extended respiratory viral panel will be accepted if any of the following criteria apply and have been documented on the request form:
These criteria have been subject to peer discussion. However, if you feel that there should be any extra testing criteria added to this list, please get in touch with us to discuss further.